產(chǎn)品名稱 |
Influenza A virus (H1N1) |
商品貨號 |
B235498 |
Classification |
Orthomyxoviridae, Influenzavirus A |
Deposited As |
Influenza A virus |
Agent |
Influenza A virus (H1N1) |
Strain |
A/PR/8/34 |
Applications |
Influenza Research |
Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Product Format |
frozen 1 mL per vial |
Storage Conditions |
-70°C or colder |
Images |
|
Comments |
VR-1469® is a TC-adapted item derived from virus passaged in eggs (ATCC® VR-95™). |
Effect on Host |
CPE, rounding, degeneration, sloughing |
Recommended Host |
MDCK cells (ATCC® CCL-34™) |
Growth Conditions |
Temperature: 35°C
Recommendations for Infection: For best results, infection should be performed on an 80-90% confluent, 18-48 hour old cellular monolayer. Prepare dilution of virus in minimum amount of volume (e.g. 1 mL per 25 cm2), optimized for propagation (e.g. MOI 0.01-0.1 recommended). Wash monolayer two times with PBS or serum free medium prior to inoculation. Adsorb virus dilution for 1-2 hours at 35°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 2-4 days at 35°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
Name of Depositor |
ATCC®, M Coleman, Centers for Disease Control and Prevention |
Special Collection |
NCRR Contract |
Source |
Patient in Puerto Rico, 1934 |
References |
Francis T. Immunological relationships of strains of filterable virus recovered from cases of human influenza. Proc. Soc. Exp. Biol. Med. 32: 1172-1175, 1935.
|